Xiaoyang Li
- Molecular Biology top 5%
- Oncology top 5%
- Organic Chemistry top 5%
- Cancer Research
- Pharmacology top 10%
- Co-authors
- C. James ChouJesse J. McClureWenfang XuYingjie ZhangYuqi JiangElizabeth S. InksJie ZangYuping Jia
- Topics
- Histone Deacetylase Inhibitors Research (36 papers)Peptidase Inhibition and Analysis (24 papers)Protein Degradation and Inhibitors (23 papers)
- Journals
- Proceedings of the National Academy of SciencesSHILAP Revista de lepidopterologíaThe Journal of Physical Chemistry B
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Xiaoyang Li
105 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 115
- Molecular Biology 1.3k
- Oncology 497
- Organic Chemistry 443
- Cancer Research 140
- Pharmacology 131
Countries citing papers authored by Xiaoyang Li
This map shows the geographic impact of Xiaoyang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyang Li more than expected).
Fields of papers citing papers by Xiaoyang Li
This network shows the impact of papers produced by Xiaoyang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyang Li. The network helps show where Xiaoyang Li may publish in the future.
Co-authorship network of co-authors of Xiaoyang Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyang Li. A scholar is included among the top collaborators of Xiaoyang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyang Li. Xiaoyang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 2 | |
| 3 | 6 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 29 | |
| 9 | 1 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | 0 | |
| 13 | 4 | |
| 14 | 1 | |
| 15 | 1 | |
| 16 | 6 | |
| 17 | 7 | |
| 18 | 16 | |
| 19 | 26 | |
| 20 | 1 |
About Xiaoyang Li
Xiaoyang Li is a scholar working on Oncology, Molecular Biology and Cancer Research, having authored 113 papers that have together received 1.9k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (36 papers), Peptidase Inhibition and Analysis (24 papers) and Protein Degradation and Inhibitors (23 papers). The work is most often cited by research in Molecular Biology (1.3k citations), Oncology (497 citations) and Organic Chemistry (443 citations). Xiaoyang Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include C. James Chou, Jesse J. McClure, Wenfang Xu, Yingjie Zhang, Yuqi Jiang, Elizabeth S. Inks, Jie Zang, Yuping Jia, Aixin Song and Jingcheng Hao. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Physical Chemistry B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.